Group 1 - AdvanSix reported a quarterly loss of 0.10pershare,betterthantheZacksConsensusEstimateofalossof0.12, compared to earnings of 1.27pershareayearago,indicatinganearningssurpriseof16.67382.21 million for the quarter ended December 2023, exceeding the Zacks Consensus Estimate by 13.82%, although this represents a decline from year-ago revenues of 404.06million[1]−Overthelastfourquarters,AdvanSixhassurpassedconsensusEPSestimatesthreetimesandtoppedconsensusrevenueestimatestwotimes[1]Group2−AdvanSixshareshavedeclinedapproximately8.50.14 on revenues of 332.9million,whileforthecurrentfiscalyear,theestimateis1.74 on revenues of 1.49billion[4]−TheChemical−Specialtyindustry,towhichAdvanSixbelongs,iscurrentlyrankedinthetop420.11 per share, with revenues projected at $45 million, reflecting a 9% increase from the previous year [5]